| [1] |
Feig DS, Hwee J, Shah BR, et al. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996－2010[J]. Diabetes Care，2014，37(6)：1590-1596.
|
| [2] |
Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships[J]. Diabetes，2000，49(12)：2208-2211.
|
| [3] |
Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial[J]. Diabetes Care，2011，34(8)：1683-1688.
|
| [4] |
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care，2010，33(3)：676-682.
|
| [5] |
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline[J]. Diabetes Res Clin Pract，2014，103(3)：341-363.
|
| [6] |
中华医学会妇产科学分会产科学组，中华医学会围产医学分会，中国妇幼保健协会妊娠合并糖尿病专业委员会. 妊娠期高血糖诊治指南(2022)[第二部分][J]. 中华妇产科杂志，2022，57(2)：81-90.
|
| [7] |
National Diabetes Data Group. Report of the expert committee on the diagnosis and dassification of diabetes mellitus[J]. Diabetes Care，1997，20(7)：1183-1197.
|
| [8] |
Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin No. 190: gestational diabetes mellitus[J]. Obstet Gynecol，2018，131(2)：e49-64.
|
| [9] |
Davidson KW, Barry MJ, Mangione CM, et al. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement[J]. JAMA，2021，326(6)：531-538.
|
| [10] |
Mo X, Gai TR, Takahashi Y, et al. Economic evaluations of gestational diabetes mellitus screening: a systematic review[J]. J Epidemiol，2021，31(3)：220-230.
|
| [11] |
Berger H, Gagnon R, Sermer M. Guideline No. 393-diabetes in pregnancy[J]. J Obstet Gynaecol Can，2019，41(12)：1814-1825.
|
| [12] |
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid，2011，21(10)：1081-1125.
|
| [13] |
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid，2017，27(3)：315-389.
|
| [14] |
中华医学会内分泌学分会，中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华内分泌代谢杂志，2012，28(5)：354-371.
|
| [15] |
《妊娠和产后甲状腺疾病诊治指南》(第2版)编撰委员会，中华医学会内分泌学分会，中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南(第2版)[J]. 中华内分泌代谢杂志，2019，35(8)：636-665.
|
| [16] |
ACOG committee. Thyroid disease in pregnancy: ACOG practice bulletin, Number 223[J]. Obstet Gynecol，2020，135(6)：e261-274.
|
| [17] |
汤绍芳，刘铭. 泌乳素瘤患者的围妊娠期管理[J]. 国际内分泌代谢杂志，2021，41(6)：569-572.
|
| [18] |
Luger A, Broersen L, Biermasz NR, et al. ESE clinical practice guideline on functioning and nonfunctioning pituitary adenomas in pregnancy[J]. Eur J Endocrinol，2021，185(3)：G1-33.
|
| [19] |
Krupp P, Monka C. Bromocriptine in pregnancy: safety aspects[J]. Klin Wochenschr，1987，65(17)：823-827.
|
| [20] |
Raymond J P, Goldstein E, Konopka P, et al. Follow-up of children born of bromocriptine-treated mothers[J]. Horm Res，1985，22(3)：239-246.
|
| [21] |
Kuhn E, Weinreich AA, Biermasz NR, et al. Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature[J]. Eur J Endocrinol，2021，185(1)：99-108.
|
| [22] |
Molitch ME. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma[J]. Eur J Endocrinol，2015，172(5)：R205-213.
|
| [23] |
中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志，2020，36(9)：737-750.
|
| [24] |
Sarathi V, Lila AR, Bandgar TR, et al. Pheochromocytoma and pregnancy: a rare but dangerous combination[J]. Endocr Pract，2010，16(2)：300-309.
|
| [25] |
Mannelli M, Bemporad D. Diagnosis and management of pheochromocytoma during pregnancy[J]. J Endocrinol Invest，2002，25(6)：567-571.
|
| [26] |
Schenker JG, Chowers I. Pheochromocytoma and pregnancy. Review of 89 cases[J]. Obstet Gynecol Surv，1971，26(11)：739-747.
|
| [27] |
Langton K, Tufton N, Akker S, et al. Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome-a systematic review[J]. BJOG，2021，128(8)：1264-1272.
|
| [28] |
Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy[J]. Br J Surg，2013，100(2)：182-190.
|
| [29] |
Eccles-Smith J, Hopkins S, Conn J, et al. Paraganglioma in pregnancy: a case series and literature review[J]. Obstet Med，2022，15(1)：19-24.
|
| [30] |
Bancos I, Atkinson E, Eng C, et al. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature[J]. Lancet Diabetes Endocrinol，2021，9(1)：13-21.
|
| [31] |
Fishbein L, Merrill S, Fraker DL, et al. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing[J]. Ann Surg Oncol，2013，20(5)：1444-1450.
|
| [32] |
Clifton-Bligh RJ. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy[J]. Rev Endocr Metab Disord，2023，24(1)：49-56.
|
| [33] |
贺芳，王永，唐小林，等. 妊娠合并嗜铬细胞瘤7例报道并文献复习[J]. 中华围产医学杂志，2017，20(7)：538-541.
|
| [34] |
Mcmullen TP, Learoyd DL, Williams DC, et al. Hyperparathyroidism in pregnancy: options for localization and surgical therapy[J]. World J Surg，2010，34(8)：1811-1816.
|
| [35] |
Gokkaya N, Gungor A, Bilen A, et al. Primary hyperparathyroidism in pregnancy: a case series and literature review[J]. Gynecol Endocrinol，2016，32(10)：783-786.
|
| [36] |
Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop[J]. J Bone Miner Res，2022，37(11)：2293-2314.
|
| [37] |
Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management[J]. Obstet Gynecol Surv，2002，57(6)：365-376.
|
| [38] |
Lopes MP, Kliemann BS, Bini IB, et al. Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications[J]. Arch Endocrinol Metab，2016，60(6)：532-536.
|
| [39] |
Aceto TJ, Batt RE, Bruck E, et al. Intrauterine hyperparathyroidism: a complication of untreated maternal hypoparathyroidism[J]. J Clin Endocrinol Metab，1966，26(5)：487-492.
|
| [40] |
Alikasifoglu A, Gonc EN, Yalcin E, et al. Neonatal hyperparathyroidism due to maternal hypoparathyroidism and vitamin D deficiency: a cause of multiple bone fractures[J]. Clin Pediatr (Phila)，2005，44(3)：267-269.
|
| [41] |
Rigg J, Gilbertson E, Barrett HL, et al. Primary hyperparathyroidism in pregnancy: maternofetal outcomes at a quaternary referral obstetric hospital, 2000 through 2015[J]. J Clin Endocrinol Metab，2019，104(3)：721-729.
|
| [42] |
Ali DS, Dandurand K, Khan AA. Hypoparathyroidism in pregnancy and lactation: current approach to diagnosis and management[J]. J Clin Med，2021，10(7)：1-14.
|
| [43] |
Caimari F, Valassi E, Garbayo P, et al. Cushing′s syndrome and pregnancy outcomes: a systematic review of published cases[J]. Endocrine，2017，55(2)：555-563.
|
| [44] |
安平，陈康，母义明. 妊娠女性库欣综合征的临床诊治[J]. 中华内分泌代谢杂志，2020，36(2)：180-184.
|
| [45] |
Sridharan K, Sahoo J, Palui R, et al. Diagnosis and treatment outcomes of Cushing′s disease during pregnancy[J]. Pituitary，2021，24(5)：670-680.
|
| [46] |
Husebye ES, Pearce SH, Krone NP, et al. Adrenal insufficiency[J]. Lancet，2021，397(10274)：613-629.
|
| [47] |
Lee JH, Torpy DJ. Adrenal insufficiency in pregnancy: physiology, diagnosis, management and areas for future research[J]. Rev Endocr Metab Disord，2023，24(1)：57-69.
|
| [48] |
Kamoun M, Mnif MF, Charfi N, et al. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies[J]. Am J Med Sci，2014，347(1)：64-73.
|